Nausea and Vomiting, Postoperative Clinical Trial
Official title:
The Role Of Laserpuncture For Prevention Of Nausea And Vomiting Post Strabismus Surgery With General Anesthesia In Adult Patients
NCT number | NCT06302673 |
Other study ID # | 23081229 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | October 9, 2023 |
Est. completion date | October 2024 |
This study to determine the effectiveness of a combination of pre-surgical laserpuncture with standard anti-emetic therapy for PONV symptoms in adult patients after strabismus surgery under general anesthesia compared to a combination of pre-surgical placebo laserpuncture with standard anti-emetic therapy. Research design using a double blinded randomized controlled trial (RCT) where research subjects and data takers who will be disguised. The research will be carried out in the Operation and Inpatient Room, Kirana Building, RSUPN Dr. Cipto Mangunkusumo (RSCM) with research subjects as adult patients undergoing strabismus surgery under general anesthesia. Assessment of nausea and vomiting using AVS ( Analog Visual Scale) consists of scoring using a score from 1-5 which indicates the severity of nausea and vomiting.
Status | Recruiting |
Enrollment | 32 |
Est. completion date | October 2024 |
Est. primary completion date | October 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 59 Years |
Eligibility | Inclusion Criteria: 1. Adult patients aged 18-59 years. 2. Patients undergoing simple strabismus surgery involving no more than two muscles without transposition under general anesthesia. 3. Meets the ASA (American Society of Anesthesiologists) score of 1-2. 4. Complete the surgical preparations according to the presedation sheet. 5. Sign the informed consent sheet. 6. Patients who can communicate with the research team. 7. Patients undergoing surgery <3 hours. Exclusion Criteria: 1. The patient is pregnant. 2. Patients who have a history of drug or drug abuse. 3. Patients with hypersensitivity to laser light. 4. There are wounds or skin disorders at the radiation site (skin TB, SLE(Systemic Lupus Erythematosus) skin 5. Patients who have gastrointestinal diseases (intestinal obstruction, peristaltic disorders gastrointestinal tract, gastroenteritis, irritable bowel syndrome, dyspepsia,gastroesophageal reflux disease/GERD, appendicitis, hepatitis, cholecystitis, inflammatory bowel synchrome, pancreatitis, peptic ulcer, peritonitis, food poisoning). 6. Patients with metabolic diseases (acid-base imbalance, metabolic diseases calcium, glucose metabolism disease, hyperlactemia, mitochondrial disease, phenylketonuria) 7. Patients with conditions of high intracranial pressure, head trauma, migraines, disease with symptoms of seizures, vestibular diseases, malignancies, mental and psychogenic diseases, diseases arising from consumption of drugs, nephrolithiasis, other kidney diseases, myocardial infarction, as well as the occurrence of nausea and vomiting before surgery. 8. Infection accompanied by high fever (temperature >38°C) |
Country | Name | City | State |
---|---|---|---|
Indonesia | RSUPN Dr. Cipto Mangunkusumo | Jakarta Pusat | Jakarta |
Lead Sponsor | Collaborator |
---|---|
Indonesia University |
Indonesia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Analog Visual Scale for nausea vomitting | PONV (post operative nausea vomiting) assessment based on the onset of nausea
vomit that has value 1-5. 1 = No nausea and vomiting. 2 = Nausea and possible vomiting tolerated, with the nausea episode can't remember by the patient or intensity nausea low with one vomiting episodes (not needed antiemetic additional inside both events). Ordinal 57 3 = Nausea and vomiting, with episodes that don't can be remembered and need antiemetic. 4 = Nausea and possible vomiting remembered clearly and need antiemetic for control symptom. 5=Nausea and persistent vomiting, with nothing symptom improvement even if given antiemetic. |
30 minutes after surgery, 2 hours after surgery, 6 hours after surgery, and 12 hours after surgery. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01217190 -
Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets
|
Phase 1/Phase 2 | |
Recruiting |
NCT04563494 -
The Effects of IV vs Oral Dexamethasone on Postoperative Nausea, Vomiting, and Pain
|
Phase 4 | |
Completed |
NCT00108095 -
A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting
|
Phase 2 | |
Not yet recruiting |
NCT05426278 -
The Effect Of Intraoperative Forced Air Warmer Use, On Postoperative Nausea And Vomiting
|
N/A | |
Withdrawn |
NCT04954365 -
Post Operative Nausea and Vomiting (PONV) Rescue Outcomes After Amisulpride Treatment
|
||
Not yet recruiting |
NCT06356623 -
A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer
|
||
Withdrawn |
NCT05016076 -
Multi-Strategy Intervention for Anesthesia Care of Obese Patients A Factorial Randomized Controlled Trial
|
N/A | |
Not yet recruiting |
NCT04899817 -
Granisteron Versus Metoclopramide in Laparoscopic Cholecystectomy
|
Phase 4 | |
Recruiting |
NCT05875077 -
Propofol Versus Dexmedetomidine on the Incidence of Postoperative Nausea and Vomiting
|
N/A | |
Completed |
NCT03338400 -
Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role?
|
Phase 2 | |
Completed |
NCT05692245 -
Dexamethasone vs Ondansetron After Cesarean Delivery
|
Phase 4 | |
Completed |
NCT03125941 -
High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy
|
Phase 4 | |
Completed |
NCT00326248 -
Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women
|
Phase 3 | |
Completed |
NCT00334152 -
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
|
Phase 3 | |
Recruiting |
NCT03586817 -
PALONOSETRON X FOSAPREPITANT IN PONV
|
Phase 4 | |
Not yet recruiting |
NCT06357234 -
Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery
|
Phase 2 | |
Completed |
NCT03045133 -
QUALITY OF RECOVERY AFTER INTRAOPERATIVE MORPHINE OR METHADONE
|
Phase 4 | |
Not yet recruiting |
NCT06410365 -
Impact of Intrathecal vs Intravenous Dexmedetomidine
|
Phase 4 | |
Recruiting |
NCT05474001 -
Comparison Between IT Fentanyl and IV Granisetron in Prevention of Vomiting in CS Under Spinal Anesthesia
|
N/A | |
Enrolling by invitation |
NCT05439798 -
Effect of Palonosetron, Ondansetron and Dexamethasone in the Prevention of Postoperative Nausea and Vomiting
|
Phase 3 |